As the most common neoplasm arising from the kidney, renal cell carcinoma (RCC) continues to have a significant impact on global health. Conventional cross-sectional imaging has always served an important role in the staging of RCC. However, with recent advances in imaging techniques and postprocessing analysis, magnetic resonance imaging (MRI) now has the capability to function as a diagnostic, therapeutic, and prognostic biomarker for RCC. For this narrative literature review, a PubMed search was conducted to collect the most relevant and impactful studies from our perspectives as urologic oncologists, radiologists, and computational imaging specialists. We seek to cover advanced MR imaging and image analysis techniques that may improve the management of patients with small renal mass or metastatic renal cell carcinoma.

+More

mr imaging and image analysis techniques renal cell carcinoma urologic oncologists radiologists staging of rcc magnetic resonance imaging postprocessing conventional crosssectional imaging

Yan Wu,Young Suk Kwon,Mina Labib,David J. Foran,Eric A. Singer,.Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma. 2015 (),.

Yan Wu,Young Suk Kwon,Mina Labib,David J. Foran,Eric A. Singer,"Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma" 2015

Yan Wu,Young Suk Kwon,Mina Labib,David J. Foran,Eric A. Singer,"Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma"